Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Michael_Amoroso
|
| gptkbp:collaboratedWith |
gptkb:Bayer
gptkb:iECURE gptkb:Servier |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
allogeneic CAR T cell therapies
|
| gptkbp:focusesOn |
genome editing
gene therapy |
| gptkbp:foundedIn |
2006
|
| gptkbp:founder |
gptkb:Derek_Jantz
gptkb:Matthew_Kane gptkb:Jeff_Smith |
| gptkbp:headquartersLocation |
gptkb:Durham,_North_Carolina,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Precision Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
gptkb:PBCAR0191
gptkb:PBCAR19B gptkb:PBCAR269A |
| gptkbp:platform |
gptkb:ARCUS_genome_editing_technology
|
| gptkbp:specializesIn |
off-the-shelf cell therapies
|
| gptkbp:stockSymbol |
gptkb:DTIL
|
| gptkbp:website |
https://precisionbiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Laura_Deming
|
| gptkbp:bfsLayer |
6
|